If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnteq Tech Regulatory News (NTQ)

  • This share is currently suspended. It was suspended at a price of 0.4999
  • There is currently no data for NTQ

Licence Agreement with Shell for drilling tech

10 Sep 2019 11:29

RNS Number : 8359L
Enteq Upstream PLC
10 September 2019
 

10 September 2019

 

 

 

Enteq Upstream plc

("Enteq"")

 

 

Licence Agreement with Shell for drilling technology

 

Enteq, the oilfield services technology and equipment supplier, is pleased to announce that on 10 September 2019 it jointly signed a license agreement with Shell Global Solutions (US) Inc. and Shell Global Solutions International, both subsidiaries of Royal Dutch Shell plc ("Shell") (the "Licence"). This Licence gives Enteq exclusive rights to incorporate Shell's patented intellectual property plus other technology (the "Information") into the engineering and manufacture of a specialised Rotary Steerable drilling system.

 

Rotary Steerable systems are becoming a new standard for fast and efficient drilling of oil, gas and geothermal wells. The combination of Shell's Information and Enteq's proven track record of product innovation, engineering and commercialisation offer the potential to produce a "next generation" type of product utilising a novel and unique steering method with potential significant cost reductions and other benefits of operation.

 

The Rotary Steerable drilling market is currently estimated at $1bn within the globally assumed $10bn directional drilling sector for Oil and Gas and expected to grow at 7% CAGR.

 

The Information and License relate to a system that has currently been deployed and tested in an early stage prototype. Enteq envisages that the development of a commercial system will take up to a further two years and may require a total investment of up to approximately $3m over that period, including some initial payments to Shell. Additional expenditure for the subsequent build of trial and commercial inventory would be required and royalty payments will be due to Shell when commercial.

 

Adrian Chesters, Shell General Manager Wells Technology commented "Enteq is a strong licensee and collaborator for this project due to its status as an independent supplier with access to the directional drilling market. Their interest in further developing and commercialising the technology aligns well with our own."

 

Martin Perry, Enteq's Chief Executive Officer commented "The Enteq team has a track record in commercialising innovative engineering projects which have achieved good market share. We look forward to building upon Shell's innovative work to date in order to bring an exciting new product to the directional drilling market."

 

Enteq will issue a trading update on 25th September 2019, ahead of the AGM that will be held later that day.

 

 

 

 

 

For further information, please contact:

 

Enteq Upstream plc +44 (0)149 461 8739

Martin Perry, Chief Executive Officer

David Steel, Finance Director

 

 

Investec Bank plc (NOMAD and Broker) +44 (0)207 597 5970

Chris Treneman, Patrick Robb, David Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRLLFFIARIILIA
Date   Source Headline
8th Jan 20243:59 pmRNSHolding(s) in Company
24th Nov 20237:00 amRNSPresenting at the MelloLondon Conference
15th Nov 20237:00 amRNSHalf-year Report
2nd Nov 202310:25 amRNSDirector/PDMR Shareholding
30th Oct 20234:08 pmRNSResult of General Meeting
23rd Oct 20237:00 amRNSAwards under the Enteq Performance Share Plan
18th Oct 202311:07 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSAppointment of Non-Executive Director
6th Oct 20232:25 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
29th Sep 20237:00 amRNSAGM Statement and Board Update
22nd Sep 20233:29 pmRNSNotice of Final Results
19th Sep 20232:53 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSNotice of Annual General Meeting
9th Aug 20238:25 amRNSSABER System Field Trial Update
31st Jul 20239:30 amRNSNotice of Final Results
1st Jun 20232:30 pmRNSIssue of Shares and Director/PDMR Shareholdings
1st Jun 20237:00 amRNSAppointment of new CFO
12th Apr 20237:00 amRNSSale of XXT and Year-end Trading Update
29th Mar 20237:08 amRNSSale of Property
15th Feb 20237:00 amRNSSABER Tool Update
16th Nov 20221:25 pmRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSInterim Results
21st Sep 20223:36 pmRNSResult of AGM
21st Sep 20229:05 amRNSSecond Price Monitoring Extn
21st Sep 20229:00 amRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSAGM Trading Statement
2nd Aug 20225:43 pmRNSIssue of Shares and Director/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20227:00 amRNSFinal Results and Investor Presentation
14th Apr 20221:00 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSYear-end Trading Update
8th Mar 20229:06 amRNSHolding(s) in Company
3rd Mar 20221:47 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBusiness Update and SABER Technology Progress
23rd Dec 202110:42 amRNSHolding(s) in Company
15th Dec 20213:39 pmRNSIssue of Shares and Director/PDMR Shareholding
18th Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSExclusive Distributor Agreements Signed
8th Nov 20217:00 amRNSSABER Tool – Field Trial Update
28th Oct 20217:00 amRNSChange of Name
30th Sep 20214:05 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:22 pmRNSResult of General Meeting and Change of Name
23rd Sep 20217:00 amRNSAGM Trading Statement
10th Aug 202110:30 amRNSDirector/PDMR Shareholding
26th Jul 20215:04 pmRNSDirector/PDMR Shareholding
14th Jul 20214:25 pmRNSIssue of shares and Director/PDMR Shareholding
7th Jul 20217:00 amRNSFinal Results & Investor Presentation
30th Apr 20217:00 amRNSContract award
19th Apr 20217:00 amRNSChange of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.